FSHD UK
News
// News
Clinical Trial & Studies Updates
Fulcrum Therapeutics and Sanofi collaborate to commercialize Losmapimo
Fulcrum Therapeutics Enters into a Collaboration and License...
Avidity Announces data from phase 1/2 FORTITUDE™ trial
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2...
// Events
Research News
Experimental Therapy SAT-3247 Shows Promise in FSHD Mouse Study
A new experimental therapy designed to support muscle regeneration...
// News
Special Events
Rare Disease Day
At the kind invitation of Dr. Alberto Malerba, Lecturer in Gene...